Calliditas Therapeutics AB: key financial figures for fiscal year 2023 (in SEK), standardized from XBRL/iXBRL filings by Hub-Equity:

Source: Calliditas Therapeutics AB 20-F filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.